We further demonstrated that a subset of FOXA1-dependent NSCLC models is also dependent on GR, and that FOXA1 and GR converge on the regulation of targets involved in the activation of growth factor signaling and cell-cycle progression. The gene discussed is FOXA1; the disease is non-small cell lung carcinoma.